Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Specialty pharmaceutical company Alliance Pharma (APH) has today announced an $11.5 million (£7.5 million) acquisition of all existing rights to the ‘Syntometrine’ drug from industry major Novartis. This is part of its strategy of buying in “orphan” brands from majors which it can then monetize by flogging through its existing sales infrastructure.
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Time left: 00:35:01